United Therapeutics Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About United Therapeutics Corp.
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
/ 
Frequently asked questions
To buy United Therapeutics Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for United Therapeutics Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for United Therapeutics Corp. is UTHR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
United Therapeutics Corp. has its primary listing on NASDAQ. You can trade United Therapeutics Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, United Therapeutics Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include United Therapeutics Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like United Therapeutics Corp..